PFE Earnings: 16-for-16 Beat Rate and What Traders Need to Know

Pfizer reports next on May 5, 2026, giving traders 28 days to position. With 16 consecutive quarters of beating estimates, PFE earnings odds are built on one of the most consistent records in large-cap pharma. The data tells a specific story.

The Beat Rate

Pfizer has beaten Wall Street estimates in all 16 of its last 16 quarters. A 100% PFE earnings beat rate is rare. Most S&P 500 companies hover around 70-75% over comparable periods. Pfizer is running a perfect record.

What Happens After a Beat

The stock moves up the next trading day 50% of the time after a beat. The average next-day move following a PFE earnings beat is 0.11%. For a large-cap pharmaceutical company, that tight range tells you the market is pricing in the beat before the number even drops.

The Pattern

Beating estimates does not move the needle reliably for PFE. A 50% next-day up rate is a coin flip, not an edge. The 0.11% average move suggests that Pfizer's consistent beats have trained the market to expect them, which is exactly why the beat alone stops generating upside. Options premiums around the report are often overpriced relative to the realized move.

What This Means for Traders

Do not buy the beat blindly. PFE earnings history shows a perfect 100% beat rate but only a 50% chance the stock closes green the next day. Keep position size small, because a 0.11% average move means the reward-to-risk on directional bets around earnings is thin. Watch implied volatility before the May 5 report. If IV is elevated relative to that 0.11% historical realized move, selling premium has more statistical backing than buying direction. Every number in this analysis comes directly from ChartOdds data.